MS Treatment Guideline — MS Patient Comments are being requested

Stuart SchlossmanFor the Benefit of the Patient, MS Drug Therapies, Multiple Sclerosis, Multiple Sclerosis (MS) Symptoms


                                                                  

  


Click here to receive MS news via e-mail




Guidelines Open for Public Comment

Provide your feedback on AAN draft guidelines in development. The AAN is committed to developing guidelines and evidence-based documents that incorporate patient and caregiver perspectives in a meaningful way. In addition to the draft manuscript of the full guideline provided for review, there is an accompanying summary version for lay stakeholders who wish to provide feedback, including patients, their families, caregivers, and patient advocates, to better understand the evidence and conclusions contained in the guideline. 

Review and Comment on Disease-modifying Therapies for Multiple Sclerosis Evidence-based practice guideline


Comment Period Closes October 8
Evidence-based Guideline
The AAN requests comments on the following issues: 
  • Interpretation and inclusion of evidence
  • Clarity and comprehensiveness of conclusion statements
  • Clarity and comprehensiveness of the recommendations
  • Comprehensiveness of the document
Public Summary
The AAN requests comments on the following issues: 
  • Clear explanations of condition, treatment, and supporting scientific evidence
  • Ease of understanding the document
  • Usefulness of the document
  • Completeness of the document




















MS Views and News
Providing educational information, resources and services for those affected by MS






Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews